摩熵化学
数据开放平台 数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,1,1-Trifluor-2-trifluormethyl-4,4-dimethyl-pentan | 23157-74-6

中文名称
——
中文别名
——
英文名称
1,1,1-Trifluor-2-trifluormethyl-4,4-dimethyl-pentan
英文别名
1,1,1-trifluoro-4,4-dimethyl-2-trifluoromethyl-pentane;1,1,1-Trifluoro-4,4-dimethyl-2-(trifluoromethyl)pentane
1,1,1-Trifluor-2-trifluormethyl-4,4-dimethyl-pentan化学式
CAS
23157-74-6
化学式
C8H12F6
mdl
——
分子量
222.174
InChiKey
TYUBKQVYKBUBRQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

点击查看最新优质反应信息

文献信息

  • N-alkylation of acridans
    申请人:Siemens Healthcare Diagnostics Inc.
    公开号:US11203573B2
    公开(公告)日:2021-12-21
    The present invention provides compounds used in the synthesis of chemiluminescent acridinium compounds and methods of producing these compounds. Specifically, methods are provided for the N-alkylation of acridan compounds using alkylating reagents. Typically, these alkylating reagents comprise a protected sulfonate group protected with an acid-labile protecting group.
    本发明提供了用于合成化学发光吖啶化合物的化合物以及生产这些化合物的方法。具体而言,本发明提供了使用烷基化试剂对吖啶化合物进行 N-烷基化的方法。通常情况下,这些烷基化试剂包括一个受保护的磺酸基团和一个耐酸保护基团。
  • ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
    申请人:UNIVERSAL DISPLAY CORPORATION
    公开号:US20190252627A1
    公开(公告)日:2019-08-15
    A compound including a first ligand L A of Formula I is disclosed.
  • AMINOPYRROLOTRIAZINES AS KINASE INHIBITORS
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:US20200347071A1
    公开(公告)日:2020-11-05
    The disclosure relates to compounds of formula I which are useful as kinase modulators including RIPK 1 modulation. The disclosure also provides methods of making and using the compounds for example in treatments related to necrosis or inflammation as well as other indications.
  • N-ALKYLATION OF ACRIDANS
    申请人:Siemens Healthcare Diagnostics Inc.
    公开号:US20210230119A1
    公开(公告)日:2021-07-29
    The present invention provides compounds used in the synthesis of chemiluminescent acridinium compounds and methods of producing these compounds. Specifically, methods are provided for the N-alkylation of acridan compounds using alkylating reagents. Typically, these alkylating reagents comprise a protected sulfonate group protected with an acid-labile protecting group.
查看更多